{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:40:09Z","timestamp":1790055609903,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01625-8","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:13:48Z","timestamp":1747224828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the anti-tumor effects of midazolam in non-small cell lung cancer through the lncRNA XLOC_010706\/miR-520d-5p\/STAT3\/autophagy pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Jinghua","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"7689","key":"1625_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553(7689), 446\u2013454 (2018).","journal-title":"Nature"},{"issue":"4","key":"1625_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10585-017-9862-x","volume":"35","author":"JA Dubowitz","year":"2018","unstructured":"Dubowitz, J. A., Sloan, E. K. & Riedel, B. J. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clin. Exp. Metastasis 35(4), 347\u2013358 (2018).","journal-title":"Clin. Exp. Metastasis"},{"key":"1625_CR3","doi-asserted-by":"publisher","first-page":"111113","DOI":"10.1016\/j.jclinane.2023.111113","volume":"92","author":"S Zarour","year":"2023","unstructured":"Zarour, S. et al. The association between midazolam premedication and postoperative delirium\u2014A retrospective cohort study. J. Clin. Anesth. 92, 111113 (2023).","journal-title":"J. Clin. Anesth."},{"issue":"23","key":"1625_CR4","first-page":"00228","volume":"S0007\u20130912","author":"C Barends","year":"2023","unstructured":"Barends, C. et al. Development of a pharmacokinetic and pharmacodynamic model for intranasal administration of midazolam in older adults: A single-site two-period crossover study. Br. J. Anaesth. S0007\u20130912(23), 00228\u20133 (2023).","journal-title":"Br. J. Anaesth."},{"key":"1625_CR5","doi-asserted-by":"publisher","first-page":"2813521","DOI":"10.1155\/2022\/2813521","volume":"2022","author":"Q Shen","year":"2022","unstructured":"Shen, Q., Xia, Y., Yang, L., Wang, B. & Peng, J. Midazolam suppresses hepatocellular carcinoma cell metastasis and enhances apoptosis by elevating miR-217. Comput. Math. Methods Med. 2022, 2813521 (2022).","journal-title":"Comput. Math. Methods Med."},{"issue":"1","key":"1625_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12935-021-02104-6","volume":"21","author":"T Sun","year":"2021","unstructured":"Sun, T., Chen, J., Sun, X. & Wang, G. Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p\/HOOK3 axis. Cancer Cell Int. 21(1), 401 (2021).","journal-title":"Cancer Cell Int."},{"issue":"3","key":"1625_CR7","first-page":"1365","volume":"11","author":"J Jiao","year":"2018","unstructured":"Jiao, J., Wang, Y., Sun, X. & Jiang, X. Midazolam induces A549 cell apoptosis in vitro via the miR-520d-5p\/STAT3 pathway. Int. J. Clin. Exp. Pathol. 11(3), 1365\u20131373 (2018).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1625_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154568","volume":"248","author":"M Taheri","year":"2023","unstructured":"Taheri, M., Askari, A., Hussen, B. M., Eghbali, A. & Ghafouri-Fard, S. A review on the role of MYC-induced long non-coding RNA in human disorders. Pathol. Res. Pract. 248, 154568 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"1625_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00806-9","author":"R Bhattacharjee","year":"2023","unstructured":"Bhattacharjee, R. et al. Crosstalk between long noncoding RNA and microRNA in Cancer. Cell Oncol. (Dordr.) https:\/\/doi.org\/10.1007\/s13402-023-00806-9 (2023).","journal-title":"Cell Oncol. (Dordr.)"},{"key":"1625_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154507","volume":"246","author":"R Asemi","year":"2023","unstructured":"Asemi, R. et al. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review. Pathol. Res. Pract. 246, 154507 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"1625_CR11","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.1038\/srep11671","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer. Sci. Rep. 5, 11671 (2015).","journal-title":"Sci. Rep."},{"issue":"11","key":"1625_CR12","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.3390\/ijms24119189","volume":"24","author":"AC Thomaidou","year":"2023","unstructured":"Thomaidou, A. C. et al. miRNA-guided regulation of mesenchymal stem cells derived from the umbilical cord: Paving the way for stem-cell based regeneration and therapy. Int. J. Mol. Sci. 24(11), 9189 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"1625_CR13","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms23052805","volume":"23","author":"B Smolarz","year":"2022","unstructured":"Smolarz, B., Durczy\u0144ski, A., Romanowicz, H., Szy\u0142\u0142o, K. & Hogendorf, P. miRNAs in cancer (review of literature). Int. J. Mol. Sci. 23(5), 2805 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"1625_CR14","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.18632\/aging.103831","volume":"12","author":"J Lu","year":"2020","unstructured":"Lu, J. et al. MiR-520d-5p modulates chondrogenesis and chondrocyte metabolism through targeting HDAC1. Aging (Albany NY) 12(18), 18545\u201318560 (2020).","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"1625_CR15","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.1007\/s12035-016-0302-8","volume":"54","author":"RP Deshpande","year":"2017","unstructured":"Deshpande, R. P., Chandra Sekhar, Y. B. V. K., Panigrahi, M. & Babu, P. P. SIRP alpha protein downregulates in human astrocytoma: Presumptive involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p. Mol. Neurobiol. 54(10), 8162\u20138169 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1625_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117558","volume":"254","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Liu, F., Fu, Y., Chen, X. & Zhang, D. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2. Life Sci. 254, 117558 (2020).","journal-title":"Life Sci."},{"issue":"1","key":"1625_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12885-019-5786-y","volume":"19","author":"N Miura","year":"2019","unstructured":"Miura, N., Ishihara, Y., Miura, Y., Kimoto, M. & Miura, K. miR-520d-5p can reduce the mutations in hepatoma cancer cells and iPSCs-derivatives. BMC Cancer 19(1), 587 (2019).","journal-title":"BMC Cancer"},{"issue":"11","key":"1625_CR18","first-page":"4872","volume":"9","author":"T Zhi","year":"2017","unstructured":"Zhi, T. et al. MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1. Am. J. Transl. Res. 9(11), 4872\u20134887 (2017).","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"1625_CR19","first-page":"1447","volume":"5","author":"L Yan","year":"2015","unstructured":"Yan, L. et al. SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1. Am. J. Cancer Res. 5(4), 1447\u20131459 (2015).","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"1625_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/0008-5472.CAN-16-0357","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. Gastric cancer cell proliferation and survival is enabled by a cyclophilin B\/STAT3\/miR-520d-5p signaling feedback loop. Cancer Res. 77(5), 1227\u20131240 (2017).","journal-title":"Cancer Res."},{"issue":"1","key":"1625_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12967-021-02956-6","volume":"19","author":"B Liu","year":"2021","unstructured":"Liu, B. et al. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54. J. Transl. Med. 19(1), 333 (2021).","journal-title":"J. Transl. Med."},{"key":"1625_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","volume":"31","author":"EJ Hillmer","year":"2016","unstructured":"Hillmer, E. J., Zhang, H., Li, H. S. & Watowich, S. S. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 31, 1\u201315 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1625_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154425","volume":"245","author":"HRAK Al-Hetty","year":"2023","unstructured":"Al-Hetty, H. R. A. K. et al. STAT3 signaling in pancreatic ductal adenocarcinoma: A candidate therapeutic target. Pathol. Res. Pract. 245, 154425 (2023).","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"1625_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/15548627.2015.1017192","volume":"11","author":"L You","year":"2015","unstructured":"You, L. et al. The role of STAT3 in autophagy. Autophagy 11(5), 729\u2013739 (2015).","journal-title":"Autophagy"},{"key":"1625_CR25","doi-asserted-by":"crossref","unstructured":"Elshater AA, Sadek AA, Abdelkreem E. Levetiracetam and Midazolam vs Midazolam Alone for First-Line Treatment of Children With Generalized Convulsive Status Epilepticus (Lev-Mid Study): A Randomized Controlled Trial. Indian Pediatr. S097475591600514 (2023).","DOI":"10.1007\/s13312-023-2960-8"},{"issue":"3","key":"1625_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10059-013-0050-9","volume":"36","author":"SK Mishra","year":"2013","unstructured":"Mishra, S. K. et al. Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice. Mol. Cells 36(3), 219\u2013226 (2013).","journal-title":"Mol. Cells"},{"issue":"6","key":"1625_CR27","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00280-011-1635-7","volume":"68","author":"AM Tsimberidou","year":"2011","unstructured":"Tsimberidou, A. M. et al. Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer. Cancer Chemother. Pharmacol. 68(6), 1507\u20131516 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"1625_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s11658-023-00447-8","volume":"28","author":"A Safi","year":"2023","unstructured":"Safi, A. et al. The role of noncoding RNAs in metabolic reprogramming of cancer cells. Cell Mol. Biol. Lett. 28(1), 37 (2023).","journal-title":"Cell Mol. Biol. Lett."},{"key":"1625_CR29","doi-asserted-by":"publisher","first-page":"1156494","DOI":"10.3389\/fendo.2023.1156494","volume":"14","author":"P Maroni","year":"2023","unstructured":"Maroni, P., Gomarasca, M. & Lombardi, G. Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers. Front. Endocrinol. (Lausanne) 14, 1156494 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"1625_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000110","volume":"8","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J. Immunother. Cancer 8(1), e000110 (2020).","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"1625_CR31","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11033-022-07995-w","volume":"50","author":"S Rajakumar","year":"2023","unstructured":"Rajakumar, S. et al. Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer. Mol. Biol. Rep. 50(2), 1727\u20131741 (2023).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"1625_CR32","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1038\/s41467-023-39160-7","volume":"14","author":"R Esposito","year":"2023","unstructured":"Esposito, R. et al. Tumour mutations in long noncoding RNAs enhance cell fitness. Nat. Commun. 14(1), 3342 (2023).","journal-title":"Nat. Commun."},{"issue":"14","key":"1625_CR33","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He, B. et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int. J. Biol. Sci. 16(14), 2628\u20132647 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"1625_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216659","volume":"587","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics. Cancer Lett. 587, 216659 (2024).","journal-title":"Cancer Lett."},{"key":"1625_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","volume":"17","author":"Q Lu","year":"2024","unstructured":"Lu, Q. et al. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J. Hematol. Oncol. 17, 16 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"1625_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00262-023-03366-x","volume":"72","author":"A Rizzo","year":"2023","unstructured":"Rizzo, A. et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study. Cancer Immunol. Immunother. 72, 1381\u20131394 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"1625_CR37","doi-asserted-by":"publisher","first-page":"1039121","DOI":"10.3389\/fmolb.2022.1039121","volume":"9","author":"DC Guven","year":"2022","unstructured":"Guven, D. C. et al. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front. Mol. Biosci. 9, 1039121 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"1625_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/imt-2020-0179","volume":"13","author":"FG Dall\u2019Olio","year":"2021","unstructured":"Dall\u2019Olio, F. G. et al. Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: A meta-analysis. Immunotherapy 13, 257\u2013270 (2021).","journal-title":"Immunotherapy"},{"key":"1625_CR39","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41416-022-01929-w","volume":"127","author":"A Rizzo","year":"2022","unstructured":"Rizzo, A. Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: A matter of debate. Br. J. Cancer 127, 1381\u20131382 (2022).","journal-title":"Br. J. Cancer"},{"key":"1625_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue, W. et al. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell Mol. Life Sci. 81, 79 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"1625_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114168","volume":"158","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo, M. et al. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomed. Pharmacother. 158, 114168 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1625_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124165","volume":"238","author":"J Ruan","year":"2023","unstructured":"Ruan, J. et al. Colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review. Int. J. Biol. Macromol. 238, 124165 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"1625_CR43","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.2147\/OTT.S287354","volume":"14","author":"B Ahmad","year":"2021","unstructured":"Ahmad, B. et al. Natural polyphyllins (I, II, D, VI, VII) reverses cancer through apoptosis, autophagy, mitophagy, inflammation, and necroptosis. Onco Targets Ther. 14, 1821\u20131841 (2021).","journal-title":"Onco Targets Ther."},{"issue":"5","key":"1625_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/ph16050671","volume":"16","author":"RN Laribee","year":"2023","unstructured":"Laribee, R. N., Boucher, A. B., Madireddy, S. & Pfeffer, L. M. The STAT3-regulated autophagy pathway in glioblastoma. Pharmaceuticals (Basel) 16(5), 671 (2023).","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01625-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:05:31Z","timestamp":1747227931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01625-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the animal ethics committee of Central Hospital of Shenyang Medical College. Animal care and experiments were conducted in compliance with Institutional Animal Care and Use Committee and NIH guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"16796"}}